Non-canonical RNA caps - cellular reaction to environment and stress

This project aims to investigate the role of non-canonical RNA caps (NpnNs) in prokaryotes and eukaryotes, focusing on their identification, metabolism, and impact on cellular stress responses.

Subsidie
€ 1.497.425
2022

Projectdetails

Introduction

The goal of this project is to understand the role of non-canonical RNA caps (mainly dinucleoside polyphosphates = NpnNs) in prokaryotes and eukaryotes. The 5' termini of the RNA are critical structures and are the least characterized among RNA modifications. In this project, we will develop selective capturing techniques for identification of NpnN-RNA sequences and identify the interacting partners of NpnN-RNA. Furthermore, we will reveal their metabolism and their role in cellular reaction to stress conditions in prokaryotes and eukaryotes.

Background

Until recently, only canonical structures, NAD or CoA, have been known as 5' RNA caps. We discovered an entirely new class of 5' RNA caps - dinucleoside polyphosphates (NpnN) in prokaryotic and eukaryotic cells. Based on our preliminary data, we know that methylated NpnN caps stabilize RNA of E. coli in the stationary phase and that some NpnN caps can also be found in mammalian cells.

Research Questions

We do not yet know:

  1. The sequence of RNAs capped with NpnNs.
  2. How many types of NpnN RNA caps exist in eukaryotes.
  3. Whether RNA stabilization is their only role.
  4. Why there are so many types of NpnN RNA caps (we identified nine in E. coli).
  5. Whether NpnN-RNA can be translated, etc.

Alarmones and Their Mechanism

The role of free NpnNs, identified fifty years ago, is yet to be elucidated. NpnNs are called alarmones, as their concentration increases under stress conditions. The mechanism by which the alarm is recognized in cells is unknown.

Hypothesis

I presume that their cellular effects are mediated by the RNA, where they serve as RNA caps. As such, they become an important part of RNA metabolism and can be recognized by various RNA interacting proteins, triggering additional effects in cellular metabolism.

Potential Impact

The presented project has the potential to solve the puzzle of the role of NpnNs and clarify the connection between RNA metabolism and immune response or virulence factors of viruses and bacteria.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.497.425
Totale projectbegroting€ 1.497.425

Tijdlijn

Startdatum1-4-2022
Einddatum31-3-2027
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • USTAV ORGANICKE CHEMIE A BIOCHEMIE, AV CR, V.V.I.penvoerder

Land(en)

Czechia

Vergelijkbare projecten binnen European Research Council

ERC Consolid...

Mapping and Direct Sequencing of the Non-Canonical Cap Code

Develop a single-molecule sequencing method to analyze native RNA caps and create a cap-ome atlas to elucidate the functions of non-canonical caps in eukaryotes.

€ 2.000.000
ERC Consolid...

Non-canonical modification of viral RNA

This project aims to characterize viral RNA modifications, particularly the unique 5'FAD cap in HCV, to understand their role in immune evasion and identify potential antiviral targets.

€ 1.996.986
ERC Starting...

Conjugation of NAD-capped RNAs to proteins by ADP-ribosyltransferases to generate RNA therapeutics

This project aims to develop RNAylated proteins as innovative RNA therapeutics by establishing design principles and delivery strategies to regulate cellular processes, including targeting the p53 protein.

€ 1.499.162
ERC Starting...

NTase Products and Cyclic Nucleotide Signalling

This project aims to discover novel cyclic nucleotides and their signaling pathways in humans, focusing on uncharacterized nucleotidyltransferases to enhance immune responses and therapeutic options.

€ 1.755.873
ERC Advanced...

Understanding the molecular principles governing mRNP architecture

The GOVERNA project aims to elucidate the structure and function of eukaryotic mRNPs by purifying and analyzing their composition using advanced biochemical and imaging techniques.

€ 2.171.250